CAMBRIDGE BIOTECH CORPORATION – Trademark Portfolio

Entity Type: 03

CAMBRIDGE BIOTECH CORPORATION holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ROTACLONE and ADENOCLONE. The owner is based in WORCESTER, MA.

MA BIOTECH RESEARCH PARK

365 PLANTATION STREET

WORCESTER, MA 01605

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CAMBRIDGE BIOTECH CORPORATION's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (3 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does CAMBRIDGE BIOTECH CORPORATION have?

CAMBRIDGE BIOTECH CORPORATION has 10 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 7 cancelled.

What trademark classes does CAMBRIDGE BIOTECH CORPORATION file in?

CAMBRIDGE BIOTECH CORPORATION files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are CAMBRIDGE BIOTECH CORPORATION's most well-known trademarks?

CAMBRIDGE BIOTECH CORPORATION's registered trademark portfolio includes well-known marks such as ROTACLONE and ADENOCLONE. These are among 2 currently registered trademarks in the portfolio.

What is CAMBRIDGE BIOTECH CORPORATION's trademark registration success rate?

CAMBRIDGE BIOTECH CORPORATION has a 20% trademark registration rate, with 2 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.